Skip to main content
. 2022 May 16;14(5):1066. doi: 10.3390/pharmaceutics14051066

Table 2.

SARS-CoV-2-induced immunopathology in humans: symptoms and clinical consequences.

SL No. Organ System Clinical Outcomes Clinical Manifestations References
1. Vascular system
  • Cytokine storm

  • Lymphocyte count

  • Thrombocytopenia-associated mortality

  • ARDS

  • Vasculitis and vascular dysfunction

  • Elevated IL-6, TNFα, and IL-1β

  • Elevated T helper 17 cells (TH17), plasma cells, CD8+ T cell activity, and decreased regulatory T cells

  • Reduced platelet to lymphocyte ratio

  • Elevated levels of ferritin

  • Elevated VEGF, IL-10, and IL-8

[72,73]
2. Lungs
  • Pneumonia with ARDS and dyspnea

  • Elevated IL-6, TNFα, IL-1β, IL-10, and IL-8

[69,74]
3. Kidneys
  • Proteinuria and hematuria

  • Elevated urea and creatinine levels

[75,76]
4. Liver
  • Steatosis and abnormal liver function

  • Elevated AST, ALT, CRP, and albumin levels

[77,78]
5. Heart
  • Acute myocardial injury and chronic CVS damage

  • Elevated CK and LDH levels

[73,79]
6. Intestine
  • Microbial infection, diarrhea, and severe acute ulcerative colitis

  • Reduced T cell and NK cell count (Lymphopenia)

[75,80]
7. Brain
  • Encephalopathy, headache, and ischemic stroke

  • Elevated CRP, D-dimer, and ferritin levels

[81,82]

Note: NK—natural killer, LDH—lactate dehydrogenase, CRP—C-reactive protein, AST—aspartate transaminase, TNF—tumor necrosis factor, IL—interleukin, ALT—alanine transaminase.